Anti-cancer potential of flavonoids: Recent trends and future perspectives

3 Biotech

Volumn 3, Issue 6, 2013, Pages 439-459

  Batra, Priya ^a   Sharma, Anil K ^a  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

Author keywords

Anti cancer; Breast cancer; Dietary flavonoids; Flavonoids; Health benefits; Therapeutic potential

Indexed keywords

ANTHOCYANIDIN; ANTHOCYANIN; APIGENIN; AROMATASE INHIBITOR; CATECHIN; CHRYSIN; CYCLIN DEPENDENT KINASE INHIBITOR; FLAVANOL DERIVATIVE; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOID GLYCOSIDE; FLAVONOL; FLUOROURACIL; GLUCURONOSYLTRANSFERASE; ISOFLAVONOID; JANUS KINASE; LUTEOLIN; MULTIDRUG RESISTANCE PROTEIN; PHYTOESTROGEN; PLANT EXTRACT; PROANTHOCYANIDIN; PROMYELOCYTIC LEUKEMIA PROTEIN; QUERCETIN; SCRAMBLASE; SCUTELLARIA BAICALENSIS EXTRACT; STAT PROTEIN; TECOMA STANS EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BILE DUCT CARCINOMA; BIOAVAILABILITY; BREAST CANCER; CANCER CELL LINE; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CHEMICAL CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; COLON CANCER; COLORECTAL CANCER; CYTOTOXICITY; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; IC 50; INTRACELLULAR SIGNALING; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; MAXIMUM PLASMA CONCENTRATION; MOUTH CANCER; MULTICENTER STUDY (TOPIC); NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTAKE; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RANDOM AMPLIFIED POLYMORPHIC DNA; RECTUM CANCER; REVIEW; SKIN CANCER; SKIN PAPILLOMA; STOMACH CANCER; THYROID CANCER;

EID: 84899440422     PISSN: 2190572X     EISSN: 21905738     Source Type: Journal    
DOI: 10.1007/s13205-013-0117-5     Document Type: Review

References (255)

1. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3:32-40.
2. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, Payrastre B (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol-3 kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53(11):1649-1657.
3. Ahmad N, Mukhtar H (2004) Cytochrome P450: a target for drug development for skin diseases. J Investig Dermatol 123:417-425.
4. Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, Lee HJ, Moon DO, Lee CM, Kang JH, Kim BH, Oh YH, Park YM (2004) Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells though inhibition of mitogen-activated-protein kinases and NF-kB. Biochem Biophys Res Commun 313: 148-155.
5. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y (1987) Genistein, a specific inhibitor of tyrosine specific protein kinase. J Biol Chem 262:5592-5595.
6. Alvarez AI, Real R, Perez M, Mendoza G, Prieto JG, Merino G (2010) Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J Pharm Sci 99:598-617.
7. Amin AR, Thakur VS, Paul RK, Feng GS, Qu CK, Mukhtar H, Agarwal ML (2007) SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG. Proc Natl Acad Sci USA 104:5419-5424.
8. Amin AR, Kucuk O, Khuri FR, Shin DM (2009) Perspectives for cancer prevention with dietary compounds. J Clin Oncol 27(16):2712-2725.
9. Anzenbacher P, Anzenbacherová E (2011) Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58(5-6):737-747.
10. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N (2000) Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 130(9): 2243-2250.
11. Arnold RS, He J, Remo A, Ritsick D, Yin-Goen Q, Lambeth JD, Datta MW, Young AN, Petros JA (2007) Nox1 expression determines cellular reactive oxygen and modulates c-fos induced growth factor, interleukin-8, and Cav-1. Am J Pathol 171(6): 2021-2032.
12. Arts ICW (2008) A review of the epidemiological evidence on tea, flavonoids, and lung cancer. J Nutr 138:1561S-1566S.
13. Arts IC, Hollman PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81:317S-325S.
14. Arts IC, Jacobs DR, Gross M, Harnack LJ, Folsom AR (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control 13:373-382.
15. Atkinson C, Warren RML, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA (2004) Red cloverderived isoflavones and mammographic breast density: a doubleblind, randomized, placebo-controlled trial. Breast Cancer Res 6:R170-R179.
16. Atmani D, Chaher N, Atmani D, Berboucha M, Debbache N, Boudaoud H (2009) Flavonoids in human health: from structure to biological activity. Curr Nutr Food Sci 5:225-237.
17. Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C, Fotsis T (2004) Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 30-kinase activity. Cancer Res 64:7936-7946.
18. Balasuriya BWN, Rupasinghe HPV (2011) Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Funct Foods Health Dis 5:172-188.
19. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson JA, Nilsson S (1998) Differential response of estrogen receptor a and estrogen receptor b to partial estrogen agonists/antagonists. Mol Pharmacol 54:105-112.
20. Barnes S (1998) Phytoestrogens and breast cancer. Ballieres Clin Endocrinol Metab 12:559-579.
21. Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, Whelton PK (2002) Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. A J Clin Nutr 76(1):93-99.
22. Bazzoli DL, Hill S, DiSilvestro RA (2002) Soy protein antioxidant actions in active, young adult women. Nutr Res 22:807-815.
23. Birt DF, Hendrich S, Wang W (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90:157-177.
24. Blagosklonny MV (2001) Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells. Leukemia 15:936-941.
25. Bobe G (2008) Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev 17:553-562.
26. Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, Rubagotti A (2004) Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 40(1):84-89.
27. Bode AM, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4:793-805.
28. Bosetti C, Rossi M, McLaughlin JK, Negri E, Talamini R, Lagiou P, Montella M, Ramazzotti V, Franceshi S, LaVecchia C (2007) Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 16(1):98-101.
29. Brand W, Schutte ME, Williamson G, van Zanden JJ, Cnubben NH, Groten JP, van Bladeren PJ, Rietjens IM (2006) Flavonoidmediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed Pharmacother 60:508-519.
30. Bridges AJ (2001) Chemical inhibitors of protein kinases. Chem Rev 101:2541-2572.
31. Brown AK, Papaemmanouil A, Bhowruth V, Bhatt A, Dover LG, Besra GS (2007) Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II. Microbiology 153:3314-3322.
32. Brueggemeier RW, Gu X, Mobley JA, Joomprabutra S, Bhat AS, Whetstone JL (2001) Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism. Ann N Y Acad Sci 948:51-66.
33. Caltagirone S, Rossi C, Poggi A, Ranalletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M (2000) Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87:595-600.
34. Carr AM (2000) Cell cycle: piecing together the p53 puzzle. Science 287:1765-1766.
35. Casagrande F, Darbon JM (2001) Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 61:1205-1215.
36. Cermak R (2008) Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol 4:17-35.
37. Cermak R, Landgraf S, Wolffram S (2004) Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br J Nutr 91:849-855.
38. Chahar MK, Sharma N, Dobhal MP, Joshi YC (2011) Flavonoids: a versatile source of anticancer drugs. Phcog Rev 5:1-12.
39. Chiu FL, Lin JK (2008) Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate 68:61-71.
40. Ciolino HP, Daschner PJ, Yeh GC (1999) Dietary flavonoids quercetin and kaempferol are ligands of aryl hydrocarbon receptor that affect CYP1A1 differentially. Biochem J 340:715-722.
41. Clifford MN (2004) Diet-derived phenols in plasma and tissues and their implications for health. Planta Med 12:1103-1114.
42. Clifford MN, Brown JE (2006) Dietary flavonoids and health-broadening the perspective. In: Andersen ØM, Markham KR (eds) Flavonoids: chemistry, biochemistry and application, pp 319-370.
43. Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D (1998) Flavonoids: a class of modulators with bifunctional interactions at ATP-and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 95:9831-9836.
44. Cotroneo MS, Wang J, Fritz WA, Eltoum IE, Lamartiniere CA (2002) Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis 23:1467-1474.
45. D'Alessandro T, Prasain J, Botting NP, Moore R, Darley-Usmar VM, Patel RP, Barnes S (2003) Polyphenols, inflammatory response, and cancer prevention: chlorination of isoflavones by human neutrophils. J Nutr 133:3773S-3777S.
46. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W (2002) Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11:815-821.
47. Dalu A, Haskell JF, Coward L, Lamartiniere CA (1998) Genistein, a component of soy, inhibits the expression of the EGF and ErbB/Neu receptors in the rat dorsolateral prostate. Prostate 37:36-43.
48. Dangles O, Dufour C (2005) Flavonoids-protein interactions. In: Andersen ØM, Markham KR (eds) Flavonoids chemistry, biochemistry and applications. CRC Press, pp 443-469.
49. Das DK (1994) Naturally occurring flavonoids: structure, chemistry, and high performance liquid chromatography methods for separation and characterization. Methods Enzymol 234:410-420.
50. De Santi C, Pietrabissa A, Mosca F, Rane A, Pacifici GM (2002) Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers. Xenobiotica 32:363-368.
51. den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH (2001) Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 10(3):223-228.
52. Dhar DN (1994) The chemistry of chalcones and related compounds. Wiley, New York.
53. Di Pietro A, Conseil G, Perez-Victoria JM, Dayan G, Baubichon-Cortaya H, Trompiera D, Steinfels E, Jault JM, de Wet H, Maitrejan M, Comte G, Boumendjel A, Mariotte AM, Dumontet C, McIntosh DB, Goffeau A, Castanys S, Gamarro F, Barron D (2002) Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol Life Sci 59:307-322.
54. Djuric Z, Chen G, Doerge DR, Heilbrun LK, Kucuk O (2001) Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett 172:1-6.
55. Doostdar H, Burke MD, Mayer RT (2000) Bioflavonoids: selective substrates and inhibitors for cytochromes P450 CYP1A and CYP1B1. Toxicology 144:31-38.
56. Fang SC, Hsu CL, Lin HT, Yen GC (2010) Anticancer effects of flavonoid derivatives isolated from Millettia reticulata Benth in SK-Hep-1 human hepatocellular carcinoma cells. J Agric Food Chem 58(2):814-820.
57. Favot L, Martin S, Keravis T, Andriantsitohaina R, Lugnier C (2003) Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis. Cardiovasc Res 59:479-487.
58. Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnic DJ (2004) A flavonoid fraction from cranberrry extract inhibits proliferation of human tumor cell lines. J Nutr 134(6):1529-1535.
59. Ferreira JFS, Luthria DL, Sasaki T, Heyerick A (2010) Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artimisin against malaria and cancer. Molecules 15:3135-3170.
60. Firestone GL, Sundar SN (2009) Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med 11:1-15.
61. Foti P, Erba D, Riso P, Spadafranca A, Criscuoli F, Testolin G (2005) Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arch Biochem Biophys 433:427-431.
62. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90:2690-2694.
63. Fotsis T, Pepper M, AdlercreutzH, Hase T, Montesano R, Schweigerer L (1995) Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125:790S-797S.
64. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wähälä K, Montesano R, Schweigerer L (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57:2916-2921.
65. Franco OH, Bonneux L, de Laet C, Peeters A, Steyerberg EW, Mackenbach JP (2004) The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 329:1447-1450.
66. Fukuyama M, Rokutan K, Sano T, Miyake H, Shimada M, Tashiro S (2005) Overexpression of a novel superoxide producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett 221(1):97-104.
67. Galijatovic A, Otake Y, Walle UK, Walle T (2001) Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells: potential role in carcinogen bioinactivation. Pharm Res 18:374-379.
68. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Payrastre B (1999) Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 32:279-286.
69. Garcia-Closas R, Gonzalez CA, Agudo A, Riboli E (1999) Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 10:71-75.
70. Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, Roat E, Bertoncelli L, Cooper EL, Cossarizza A (2011) Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med 2011:591356.
71. Giuliani C, Noguchi Y, Harii N, Napolitano G, Tatone D, Bucci I, Piantelli M, Monaco F, Kohn LD (2008) The flavonoid quercetin regulates growth and gene expression in rat FRTL-5 thyroid cells. Endocrinology 149(1):84-92.
72. Goetzl MA, VanVeldhuizen PJ, Thrasher JB (2007) Effect of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis 10:216-223.
73. Gould KS, Lister C (2005) Flavonoid functions in plants. In: Andersen OM, Markham KR (eds) Flavonoids chemistry, biochemistry and applications. CRC Press Taylor & Francis Group, London, pp 397-442.
74. Griffiths LA, Barrow A (1972) The fate of orally and parenterally administered flavonoids in the mammal. The significance of biliary excretion. Angiologica 9:30-42.
75. Guo JY, Li X, Browning JD Jr, Rottinghaus GE, Lubahn DB, Constantinou A, Bennink M, MacDonald RS (2004) Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. J Nutr 134:179-182.
76. Hackett AM (1986) The metabolism of flavonoid compounds in mammals. In: Cody V, Middleton E Jr, Harborne JB (eds) Plant flavonoids in biology and medicine: biochemical, pharmacological, and structure-activity relationships. Alan R Liss lnc, New York, pp 177-194.
77. Haddad AQ (2008) The cellular and molecular properties of flavonoids in prostate cancer chemoprevention. Ph. D Thesis, Institute of Medical Science, University of Toronto.
78. Harborne JB (ed) (1994) The flavonoids: advances in research since 1986. Chapman & Hall, London.
79. Harborne JB, Williams CA (2000) Advances in flavonoid research since 1992. Phytochemistry 55(6):481-504.
80. Haslam E (1996) Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J Nat Prod 59:205-215.
81. Hassan S, Mathesius U (2012) The role of flavonoids in root-rhizosphere signalling: opportunities and challenges for improving plant-microbe interactions. J Exp Bot 63(9):3429-3444.
82. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H (2003) Role of p53 and NF-kappaB in epigallocatechin-3-gallateinduced apoptosis of LNCaP cells. Oncogene 22:4851-4859.
83. Havsteen BH (2002) The biochemistry and medical significance of flavonoids. Pharmacol Ther 96:67-202.
84. He L, Wu Y, Lin L, Wang J, Wu Y, Chen Y, Yi Z, Liu M, Pang X (2011) Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway. Cancer Sci 102(1):219-225.
85. Heinonen M, Rein D, Teresa Satué-Gracia M, Huang S-W, Bruce-German J, Frankel EN (1998) Effect of protein on the antioxidant activity of phenolic compounds in a lecithin-liposome oxidation system. J Agric Food Chem 46:917-922.
86. Heller W, Forkmann G (1993) Biosynthesis. In: Harborne JB (ed) The flavonoids. Advances in research since 1986. Chapman and Hall Ltd, London, pp 499-535.
87. Hertog MGL, Hollman PCH, Katan MB (1992) Content of potentially anticinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40:2379-2383.
88. Hertog MGL, Hollman PCH, van de Putte B (1993a) Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem 41:1242-1246.
89. Hertog MGL, Hollman PCH, Katan MB, Kromhout D (1993b) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 20:21-29.
90. Ho JS, Ma W, Mao DY, Benchimol S (2005) p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol 25:7423-7431.
91. Hodek P, Trefil P, Stiborova M (2002) Flavonoids: potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 139(1):1-21.
92. Hodek P, Tepla M, Krizkova J, Sulc M, Stiborova M (2009) Modulation of cytochrome P450 enzyme system by selected flavonoids. Neuro Endocrinol Lett 30(1):67-71.
93. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT (1995) McCance and Widdowson's the composition of foods, 5th edn. Royal Society of Chemistry, Cambridge.
94. Hollman PCH (2004) Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol 42(S):74-83.
95. Hollman PCH, Katan MB (1998) Absorption, metabolism, and bioavailability of flavonoids. In: Rice-Evans CA, Paker L (eds) Flavonoids in health and disease. Marcel Dekker Inc, New York, pp 483-522.
96. Hollman PCH, Katan MB (1999) Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 37:937.
97. Holzbeierlein JM, McIntosh J, Thrasher JB (2005) The role of soy phytoestrogens in prostate cancer. Curr Opin Urol 15:17-22.
98. Ingram D, Sanders K, Kolybaba M, Lopez D (1997) Case control study of phyto-oestrogens and breast cancer. Lancet 350:990-994.
99. Johnson IT (2004) New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat Res 551(1-2):9-28.
100. Johnson DW, Berg JN, Baldwin MA et al (1996) Mutations in the activin receptor-like kinase I gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189-195.
101. Johnson J, Maher P, Hanneken A (2009) The flavonoid, eriodictyol, induces long-term protection in ARPE-19 cells through its effects on Nrf2 activation and phase II gene expression. Invest Ophthalmol Vis Sci 50(5):2398-2406.
102. Joussen AM, Rohrschneider K, Reichling J, Kirchhof B, Kruse FE (2000) Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids. Exp Eye Res 71(5):483-487.
103. Ju W, Wang X, Shi H, Chen W, Belinsky SA, Lin Y (2007) A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor kappa B pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 71:1381-1388.
104. Kameshwaran S, Suresh V, Arunachalam G, Kanthlal SK, Mohanraj M (2012) In vitro and in vivo anticancer activity of methanolic flower extract of Tecoma stans flower. Int Res J Pharm 3(3): 246-252.
105. Kang ZC, Tsai SJ, Lee H (1999) Quercetin inhibits benzo[a]pyreneinduced DNA adducts in human Hep G2 cells by altering cytochrome P-450 1A1 expression. Nutr Cancer 35:175-179.
106. Kilkkinen A, Virtamo J, Vartiainen E, Sankila R, Virtanen MJ, Adlercreutz H, Pietinen P (2004) Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 108(2):277-280.
107. Kim MH (2003) Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J Cell Biochem 89(3):529-538.
108. Kim H, Peterson TG, Barnes S (1998) Mechanisms of action of the soy isoflavone genistein: emerging role of its effects through transforming growth factor beta signaling pathways. Am J Clin Nutr 68:1418S-1425S.
109. Kim YJ et al (2004) Superoxide anion scavenging and xanthine oxidase inhibition of ({thorn})-catechin-aldehyde polycondensates. Amplification of the antioxidant property of ({thorn})-catechin by polycondensation with aldehydes. Biomacromolecules 5:547.
110. Kim JH, Kang JW, Kim MS, Bak Y, Park YS, Jung KY, Lim YH, Yoon DY (2012) The apoptotic effects of the flavonoid N101-2 in human cervical cancer cells. Toxicol In Vitro 26(1):67-73.
111. Kioka M, Hosokawa N, Komano T, Hirayoshi K, Nagata K, Ueda K (1992) Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite. FEBS Lett 301:307-309.
112. Knekt P, Jarvinen R, Reunanen A, Maatela J (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 312:478-481.
113. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560-568.
114. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, Williamson G (2004) How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80:15-21.
115. Kruse FE, Joussen AM, Fotsis T et al (1997) Inhibition of neovacularization of the eye by dietary factors exemplified by isoflavonoids. Ophthalmologie 94:152-156.
116. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and b. Endocrinology 138:863-870.
117. Kuiper GGJM, Lemmen JG, Carlsson BO, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology 139:4252-4263.
118. Kumar PS, Sucheta S, Deepa VS, Selavamani P, Latha S (2008) Antioxidant activity in some selected Indian medicinal plants. African J Biotechnol 7(12):1826-1828.
119. Kurisawa M, Chung JE, Kim YJ, Uyama H, Kobayashi S (2003) Amplification of antioxidant activity and xanthine oxidase inhibition of catechin by enzymatic polymerization. Biomacromolecules 4:469-471.
120. Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, Trichopoulos D (2008) Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes Control 19(8):813-818.
121. Lai H, Sasaki T, Singh NP, Messay A (2005) Effects of artemisinintagged holotrasferrin on cancer cells. Life Sci 76:1267-1279.
122. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC, Bergan RC (2008) Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 68:2024-2032.
123. Le Bail JC, Laroche T, Marre-Fournier F, Habrioux G (1998) Aromatase and 17b-hydroxysteroid dehydrogenase inhibition by flavonoids. Cancer Lett 133:101-110.
124. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN (2000) Intake of flavonoids and lung cancer. J Natl Cancer Inst 92:154-160.
125. Li YC (2011) Antioxidant activity of flavonoids from sweet potato vines in vitro. Adv Mater Res 236-238:2634-2638.
126. Li Y, Kucuk O, Hussain M, Abrams J, Cher ML, Sarkar FH (2006) Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-B (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Res 66:4816-4825.
127. Li J, Cheng Y, Qu W, Sun Y, Wang Z, Wang H, Tian B (2011a) Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells. Basic Clin Pharmacol Toxicol 108(2):84-93.
128. Li X, Wang JN, Huang JM, Xiong XK, Chen MF, Ong CN, Shen HM, Yang XF (2011b) Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines. Toxicol In Vitro 25(3):630-635.
129. Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA, Arnold RS (2005) Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62(2):200-207.
130. Liu SL, Lin X, Shi DY, Cheng J, Wu C, Zhang YD (2002) Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways. Arch Biochem Biophys 406:173-182.
131. Liu G, Ding L, Luo C, Yang H, Yang D, Liang G, Wang L (2006) Protection against DNA damage and inhibition of lipid peroxidation by flavones from Eremosparton songoricum (Litv) Vass. Res Chem Intermed 32(2):145-152.
132. Liu EH, Qi LW, Li P (2010) Structural relationship and binding mechanisms of five flavonoids with bovine serum albumin. Molecules 15:9092-9103.
133. Liu PX, Gao J, Chen YJ, Long W, Shen X, Tang WS (2011) Anticancer activity of total flavonoids isolated from Xianhe Yanling Recipe. Chin J Integr Med 17(6):459-463.
134. Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, Handa RJ (2004) Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 70:1188-1195.
135. Luo H, Daddysman MK, Rankin GO, Jiang BH, Chen YC (2010) Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int 10:16.
136. Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C (1997) Bioavailability of rutin and quercetin in rats. FEBS Lett 409:12-16.
137. Marchetti F, De Santi C, Vietri M, Pietrabissa A, Spisni R, Mosca F, Pacifici GM (2001) Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Xenobiotica 31:841-847.
138. McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG (2002) The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 132(10):3036-3041.
139. McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL (2004) Dietary lignan intakes and risk of pre-and postmenopausal breast cancer. Int J Cancer 111(3):440-443.
140. McRae JM, Kennedy JA (2011) Wine and grape tannin interactions with salivary proteins and their impact on astringency: a review of current research. Molecules 16:2348-2364.
141. Meng X, Lee MJ, Li C, Sheng S, Zhu N, Sang S, Ho CT, Yang CS (2001) Formation and identification of 40-O-methyl-(-)-epigallocatechin in humans. Drug Metab Dispos 29:789-793.
142. Messina MJ, Persky V, Setchell KDR, Barnes S (1994) Soy intake and cancer risk; a review of the in vitro and in vivo data. Nutr Cancer 21:114-131.
143. Middleton E, Kandaswami C (1994) The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: Harborne JB (ed) The flavonoids, advances in research since 1986. Chapman & Hall, London, pp 619-645.
144. Mitchell JH, Gardner PT, Mcphail DB, Morrice PC, Collins AR, Duthie GG (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 360:142-148.
145. Modak B, Torres R, Urzúa A (2011) Seasonal variation of the flavonoids pinocembrin and 3-O-methylgalangin, in the surface component mixture (resinous exudates and waxy coating) of Heliotropium stenophyllum. J Chil Chem Soc 56(1):532-534.
146. Molepo RS (2010) Flavonoid induction of cytochrome P450 (CYP) in human esophageal carcinoma cells: implications for chemotherapy. M. Sc Thesis, University of the Witwatersrand, Johannesberg.
147. Monasterio A, Urdaci MC, Pinchuk IV et al. (2004) Flavonoids induce apoptosis in human leukemia U937 cells through caspaseand caspase-calpaindependent pathways. Nutr cancer 50:90-100.
148. Moon YJ, Wang X, Morris ME (2006) Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20(2): 187-210.
149. Morris ME, Zhang S (2006) Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci 78:2116-2130.
150. Mueller SO, Simon S, Chae K, Metzler M, Korach KS (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor (alpha) and ER(beta) in human cells. Toxicol Sci 81:530-531.
151. Nakase I, Gallis B, Takatani-Nakase T, Oh S, Lacoste E, Singh NP, Goodlett DR, Tanaka S, Futaki S, Lai H, Sasaki T (2009) Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett 274:290-298.
152. Nardini M, Cirillo E, Natella F, Scaccini C (2002) Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem 50:5735-5741.
153. Neuhouser ML (2004) Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50(1):1-7.
154. Nijeveldt R, Nood EV, Hoorn DECV, Boelens PG, Norren KV, Leeawen PAMV (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425.
155. Nothlings U, Murphy SP, Wilkens LR, Boeing H et al (2008) A food pattern that is predictive of flavonol intake and risk of pancreatic cancer. Am J Clin Nutr 88(6):1653-1662.
156. Ofer M, Wolffram S, Koggel A, Spahn-Langguth H, Langguth P (2006) Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT? Eur J Pharm Sci 25(2-3):263-271.
157. Ogbuewu IP, Uchegbu MC, Emenalom OO, Okoli IC, Iloeje MU (2010) Overview of the chemistry of soy isoflavones, potential threats and potential therapeutic benefits. Electron J Environ Agric Food Chem 9(4):682-695.
158. Oh S, Kim BJ, Singh NP, Lai H, Sasaki T (2009) Synthesis and anticancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Cancer Lett 274:33-39.
159. Ohta T, Nakatsugi S, Watanabe K, Kawamori T, Ishikawa F, Morotomi M, Sugie S, Toda T, Sugimura T, Wakabayashi K (2000) Inhibitory effects of bifido-bacterium-fermented soy milk on PhIP-induced rat mammary carcinogenesis, with partial contribution of its component isoflavaones. Carcinogenesis 21:937-941.
160. Oikawa T, Shimamura M, Ashino H, Nakamura O, Kanayasu T, Morita I, Murota S (1992) Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor. J Antibiot (Tokyo) 45:1155-1160.
161. Okushio K, Matsumoto N, Kohri T, Suzuki M, Nanjo F, Hara Y (1996) Absorption of tea catechins into rat portal vein. Biol Pharm Bull 19:326-329.
162. Olthof MR, Hollman PC, Vree TB, Katan MB (2000) Bioavailabilities of quercetin-3-glucoside and quercetin-40-glucoside do not differ in humans. J Nutr 130:1200-1203.
163. Olthof MR, Hollman PC, Buijsman MN, van Amelsvoort JM, Katan MB (2003) Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr 133:1806-1814.
164. Ørgaard A, Jensen L (2008) The effects of soy isoflavones on obesity. Exp Biol Med 233(9):1066-1080.
165. Oršolić N, Benković V, Lisičić D, {Eth}ikić D, Erhardt J, Knežević AH (2010) Protective effects of propolis and related polyphenolic/flavonoid compounds against toxicity induced by irinotecan. Med Oncol 27(4):1346-1358.
166. Parr AJ, Bolwell GP (2000) Phenols in the plant and in man. The potential for possible nutritional enhancement of the diet by modifying phenolic content or composition. J Sci Food Agric 80:985-1012.
167. Pascual-Teresa D, Santos-Buelga S, Rivas-Gonzalo JC (2000) Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J Agric Food Chem 48:5331-5337.
168. Passamonti S, Terdoslavich M, Franca R, Vanzo A, Tramer F, Braidot E, Petrussa E, Vianello A (2009) Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr Drug Metab 10:369-394.
169. Patel MJ (2008) A review of potential health benefits of flavonoids. Lethbridge Undergrad Res J 3(2).
170. Peng W, Kuo SM (2003) Flavonoid structure affects the inhibition of lipid peroxidation in caco-2 intestinal cells at physiological concentrations. J Nutr 133(7):2184-2187.
171. Peng Y, Li QW, Jian L (2011) Antitumor activity of Scutellaria baicalensis Georgi total flavonoids on mice bearing U14 cervical carcinoma. Afr J Biotechnol 10(82):19167-19175.
172. Perez JL, Jayaprakasha GK, Cadena A, Martinez E, Hassan A, Patil BS (2010) In vivo induction of phase II detoxifying enzymes, glutathione transferase and quinone reductase by citrus triterpenoids. BMC Complement Altern Med 10:51.
173. Perez-Victoria JM, Chiquero MJ, Conseil G, Dayan G, Di Pietro A, Barron D, Castanys S, Gamarro F (1999) Correlation between the affinity of flavonoids binding to the cytosolic site of Leishmania tropica multidrug transporter and their efficiency to revert parasite resistance to daunomycin. Biochemistry 38:1736-1743.
174. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A (2009) Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 61(1):67-75.
175. Peterson J, Lagiou P, Samoli E, Lagiou A, Katsouyanni K et al (2003) Flavonoid intake and breast cancer risk: a case control study in Greece. Br J Cancer 89(7):1255-1259.
176. Petri N, Tannergren C, Holst B, Mellon FA, Bao Y, Plumb GW, Bacon J, O'Leary KA, Kroon PA, Knutson L, Forsell P, Eriksson T, Lennernas H, Williamson G (2003) Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab Dispos 31:805-813.
177. Phan TA, Yu XM, Kunnimalaiyaan M, Chen H (2011) Antiproliferative effect of chrysin on anaplastic thyroid cancer. J Surg Res 170(1):84-88.
178. Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H (2001) Serum enterolactone and risk of breast cancer: a case-control study in Eastern Finland. Cancer Epidemiol Biomarkers Prev 10:33.
179. Pike ACW, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JÅ, Carlquist M (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618.
180. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell signalling. Curr Med Chem 11(9):1163-1182.
181. Qin Y, Li Z, Chen Y, Hui H, Sun Y, Yang H, Lu Na, Guo Q (2012) III-10, a newly synthesized flavonoid, induced differentiation of human U937 leukemia cells via PKCd activation. Eur J Pharm Sci 45(5):648-656.
182. Rahman S, Salehin F, Iqbal A (2011) In vitro antioxidant and anticancer activity of young Zingiber officinale against human breast carcinoma cell lines. BMC Complement Altern Med 11:76.
183. Ravichandiran V, Ahamed HN, Nirmala S (2011) Natural flavonoids and lung cancer. Pharmacie Globale 6(2):1-9.
184. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523-1526.
185. Robards K, Antolovich M (1997) Analytical chemistry of fruit bioflavonoids. Analyst 122:11R-34R.
186. Rodriguez-Proteau R, Mata JE, Miranda CL, Fan Y, Brown JJ, Buhler DR (2006) Plant polyphenols and multidrug resistance: effects of dietary flavonoids on drug transporters in Caco-2 and MDCKIIMDR1 cell transport models. Xenobiotica 36(1):41-58.
187. Romanouskaya TV, Grinev VV (2009) Cytotoxic effect of flavonoids on leukemia cells and normal cells of human blood. Bull Exp Biol Med 148(1):57-59.
188. Rossi M, Garavello W, Talamini R, Negri E, Bosetti C, Dal Maso L, Lagiou P, Tavani A, Polesel J, Barzan L, Ramazzotti V, Franceschi S, Vecchia C (2007) Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol Biomarkers Prev 16:1621-1625.
189. Rossi M, Bosetti C, Negri E, Lagiou P, La Vecchia C (2010) Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr Cancer 62(7):871-877.
190. Roy AM, Baliga MS, Katiyar SK (2005) Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther 4:81-90.
191. Rudrabhatla P, Rajasekharan R (2005) Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors. Biochemistry 43(38):12123-12132.
192. Ruela-de-Sousa RR, Fuhler GM, Blom N, Ferreira CV, Aoyama H, Peppelenbosch MP (2010) Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis 1(1):19.
193. Russo GL (2007) Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 74(4):533-544.
194. Saewan N, Koysomboon S, Chantrapromma K (2011) Anti-tyrosinase and anti-cancer activities of flavonoids from Blumea balsamifera DC. J Med Plants Res 5(6):1018-1025.
195. Samanta A, Das G, Das SK (2011) Roles of flavonoids in plants. Int J Pharm Sci Technol 6(1):12-35.
196. Sandhar HK, Kumar B, Prasher S, Tiwari P, Salhan M, Sharma P (2011) A review of phytochemistry and pharmacology of flavonoids. Int Pharm Sci 1:25-41.
197. Sathyamoorthy N, Gilsdorf JS, Wang TT (2005) Differential effect of genistein on transforming growth factor beta1 expression in normal and malignant mammary epithelial cells. Anticancer Res 18(4A):2449-2453.
198. Sato T, Koike L, Miyata Y, Hirata M, Mimaki Y, Sashida Y, Yano M, Ito A (2002) Inhibition of activator protein-1 binding activity and phosphatidylinositol-3-kinase pathway by nobelitin, a polyhydroxy flavonoid, results in augmentation of TIMP-1 production and suppression of production of matrix metalloproteinases-1 and-9 in human fibrosarcoma HT-1080 cells. Cancer Res 62:1025-1029.
199. Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:S2073-S2085.
200. Scheline RR (1991) Handbook of mammalian metabolism of plant compounds. CRC Press, Boca Raton.
201. Schindler R, Mentlein R (2006) Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr 136(6):1477-1482.
202. Schmidt F, Knobbe CB, Frank B, Wolburg H, Weller M (2008) The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines. Oncol Rep 19:1061-1066.
203. Schroeter H, Spencer JP, Rice-Evans C, Williams RJ (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358:547-557.
204. Schroeter H, Boyd C, Spencer JP, Williams RJ, Cadenas E, Rice-Evans C (2002) MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 23:861-880.
205. Seelinger G, Merfort I, Wolfle U, Schempp CM (2008) Anticarcinogenic effects of the flavonoid luteolin. Molecules 13:2628-2651.
206. Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M (2006) Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res 66(9):4826-4834.
207. Seufi AM, Ibrahim SS, Elmaghraby TK, Hafez EE (2009) Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. J Exp Clin Cancer Res 28:80.
208. Shapiro AB, Ling V (1997) Effects of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 53:587-596.
209. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136.
210. Sivoňová M, Žitňanová I, Horáková L, Štrosová M, Muchová J, Balgavý P, Dobrota D, Ďuračková Z (2006) The combined effect of pycnogenol with ascorbic acid and trolox on the oxidation of lipids and proteins. Gen Physiol Biophys 25:379-396.
211. So FV, Guthrie N, Chambers AF, Carroll KK (1997) Inhibition of proliferation of estrogen receptor positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett 112:127-133.
212. Spencer CM et al (1988) Polyphenol complexation-some thoughts and observations. Phytochemistry 27:2397-2409.
213. Stefani ED, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, Ronco A, Olivera L (1999a) Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer 34:100-110.
214. Stefani ED, Ronco A, Mendilaharsu M, Deneo-Pellegrini H (1999b) Diet and risk of cancer of the upper aerodigestive tract-II. Nutr Oral Oncol 35:22-26.
215. Stevens JF, Page JE (2004) Xanthohumol and related prenylflavonoids from hops and beer: to your good health. Phytochemistry 65:1317-1330.
216. Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH (2005) The novel targets for antiangiogenesis of genistein on human cells. Biochem Pharmacol 69:307-318.
217. Sugatani J, Yamakawa K, Tonda E, Nishitani S, Yoshinari K, Degawa M, Abe I, Noguchi H, Miwa M (2004) The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem Pharmacol 67:989-1000.
218. Tang NP, Zhou B, Wang B, Yu RB, Ma J (2009) Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 39(6):352-359.
219. Tosetti F, Ferrari N, De Flora S, Albini A (2002) Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 16(1):2-14.
220. Tsao AS, Edward SK, Hong WK (2004) Chemoprevention of cancer. CA Cancer J Clin 54:150-180.
221. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266(1):37-56.
222. van der Logt EM, Roelofs HM, Nagengast FM, Peters WH (2003) Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 24:1651-1656.
223. Ververidis F, Trantas E, Douglas C, Vollmer G, Kretzschmar G, Panopoulos N (2007) Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: chemical diversity, impacts on plant biology and human health. Biotechnol J 2(10):1214-1234.
224. Vidya PR, Senthil MR, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S (2010) The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-jB inhibition. Eur J Pharmacol 649(1-3):84-91.
225. Vietri M, Vaglini F, Pietrabissa A, Spisni R, Mosca F, Pacifici GM (2002) Sulfation of R(-)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin. Xenobiotica 32:587-594.
226. von Moltke LL, Weemhoff JL, Bedir E, Khan IA, Harmatz JS, Goldman P, Greenblatt DJ (2004) Inhibition of human cytochromes P450 by components of Ginkgo biloba. J Pharm Pharmacol 56:1039-1044.
227. Wagner H, Farkas L (1975) Synthesis of flavonoids. In: Harborne JB, Mabry TJ, Mabry H (eds) The flavonoids. Part I. Academic Press, New York, pp 127-213.
228. Walle UK, Walle T (2002) Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. Drug Metab Dispos 30:564-569.
229. Walle T, Walle UK, Halushka PV (2001) Carbon dioxide is the major metabolite of quercetin in humans. J Nutr 131:2648-2652.
230. Wallstrom P, Wirfalt E, Janzon L, Mattisson I, Elmstahl S, Johansson U, Berglund G (2000) Fruit and vegetable consumption in relation to risk factors for cancer: a report from the Malmo Diet and Cancer Study. Public Health Nutr 3:263-271.
231. Wang B, Zhang X (2012) Inhibitory effects of Broccolini leaf flavonoids on human cancer cells. Scanning 34(1):1-5.
232. Wei H, Tye L, Bresnick E, Birt DF (1990) Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50:499-502.
233. Wei H, Bowen R, Cai Q, Barnes S, Wang Y (1995) Antioxidant and antipromotional effects of the soybean isoflavone genistein. Exp Biol Med 208(1):124-130.
234. Wiegand H, Boesch-Saadatmandi C, Regos I, Treutter D, Wolffram S, Rimbach G (2009) Effects of quercetin and catechin on hepatic glutathione-S transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats. Nutr Cancer 61:717-722.
235. Williams RJ, Spencer JPE, Rice-Evans C (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36(7):838-849.
236. Wilson RT, Wang J, Chinchilli V, Richie JP, Virtamo J, Moore LE, Albanes D (2009) Fish, vitamin D and flavonoids in relation to renal cell cancer among smokers. Am J Epidemiol 170(6):717-729.
237. Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313:17-29.
238. Wiseman H, O'Reilly J, Lim P, Garnett AP, Huang WC, Sanders TAB (1998) Antioxidant properties of the isoflavone phytoestrogen functional ingredient in soy products. In: Sadler M, Saltmarsh M (eds) Functional foods, the consumer, the products and the evidence. Royal Society of Chemistry, Cambridge, pp 80-86.
239. Wiseman H, O'Reilly JD, Adlercreutz H, Mallet AI, Bowey EA, Rowland IR, Sanders TAB (2000) Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72:395-400.
240. Wiseman H, Casey K, Clarke DB, Barnes KA, Bowey E (2002) Isoflavone aglycone and glucoconjugate content of high-and low-soy UK foods used in nutritional studies. J Agric Food Chem 50:1404-1410.
241. Wu B, Zhang Q, Shen W, Zhu J (2008) Antiproliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Mol Cell Biochem 313:125-132.
242. Xi J, Guo R (2008) Interactions of puerarin with micelles: pKa shifts and thermodynamics. J Solut Chem 37(1):107-118.
243. Xiao CW (2008) Health effects of soy protein and isoflavones in humans. J Nutr 138:1244S-1249S.
244. Xiao ZP, Peng ZY, Peng MJ, Yan WB, Ouyang YZ, Zhu HL (2011) Flavonoids health benefits and their molecular mechanism. Med Chem 11(2):169-177.
245. Xu WH, Yuan ZL (2009) Inhibition of experimental alkali-induced corneal neovascularization in rabbits by using genistein. Int J Ophthalmol (7).
246. Yang EB, Zhang K, Cheng LY, Mack P (1998) Butein, a specific protein tyrosine kinase inhibitor. Biochem Biophys Res Commun 245:435-438.
247. Yang ZF, Poon RTP, Liu Y, Lau CK et al (2006) High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesis. Mol Cancer Ther 5:2261-2270.
248. Yang SF, Yang WE, Chang HR, Chu SC, Hsieh YS (2008) Luteolin induces apoptosis in oral squamous cancer cells. J Dent Res 87:401-406.
249. Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon JH, Terao J, Tamaki T (2002) Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun 293:1458-1465.
250. Young JF, Nielsen SE, Haraldsdottir J, Daneshvar B, Lauridsen ST, Knuthsen P, Crozier A, Sandström B, Dragsted LO (1999) Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr 69:87-94.
251. Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S et al (2012) Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoSONE 7(2):e31060.
252. Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, Koenig KL, Kato I, Arslan AA, Toniolo P (2004) Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 91(1):99-105.
253. Zhang Q, Zhao XH, Wang ZJ (2008) Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol 46:2042-2053.
254. Zhou JR, Mukherjee P, Gugger ET et al (1998) Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 58:5231-5238.
255. Zi XL, Grasso AW, Kung HJ, Agarwal R (1998) A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest and anticarcinogenic effects in human prostate carcinoma DU145 cells. Cancer Res 58:1920-1929.